Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 39
Filter
1.
J Pain Res ; 15: 3399-3412, 2022.
Article in English | MEDLINE | ID: mdl-36317162

ABSTRACT

Bone pain is one of the most common forms of pain reported by cancer patients with metastatic disease. We conducted a review of oncology literature to further understand the epidemiology of and treatment approaches for metastatic cancer-induced bone pain and the effect of treatment of painful bone metastases on the patient's quality of life. Two-thirds of patients with advanced, metastatic, or terminal cancer worldwide experience pain. Cancer pain due to bone metastases is the most common form of pain in patients with advanced disease and has been shown to significantly reduce patients' quality of life. Treatment options for cancer pain due to bone metastases include nonsteroidal anti-inflammatory drugs, palliative radiation, bisphosphonates, denosumab, and opioids. Therapies including palliative radiation and opioids have strong evidence supporting their efficacy treating cancer pain due to bone metastases; other therapies, like bisphosphonates and denosumab, do not. There is sufficient evidence that patients who experience pain relief after radiation therapy have improved quality of life; however, a substantial proportion are nonresponders. For those still requiring pain management, even with available analgesics, many patients are undertreated for cancer pain due to bone metastases, indicating an unmet need. The studies in this review were not designed to determine why cancer pain due to bone metastases was undertreated. Studies specifically addressing cancer pain due to bone metastases, rather than general cancer pain, are limited. Additional research is needed to determine patient preferences and physician attitudes regarding choice of analgesic for moderate to severe cancer pain due to bone metastases.

2.
Curr Rheumatol Rep ; 20(12): 88, 2018 11 21.
Article in English | MEDLINE | ID: mdl-30465131

ABSTRACT

PURPOSE OF REVIEW: Osteoarthritis (OA) is the most common form of arthritis that is characterized by loss of articular cartilage and new formation of bone. Pain and functional disability are common features that lead to disability and poor quality of life. This review discusses the current state of knowledge concerning the treatment of pain in OA, with a focus on pharmacological treatments. This includes the use of non-steroidal anti-inflammatory drugs, acetaminophen, and other disease-modifying agents. RECENT FINDINGS: An updated review of the role of anti-nerve growth factor monoclonal antibodies and other novel agents in the treatment of OA is also presented. In addition, a discussion of current research on biological agents such as small molecules targeting ion channels and G protein-coupled receptors is included. These new pharmacological interventions expand the frontier for treatment of patients with OA. The purpose of the review is to provide clinicians with information about the effectiveness of different pharmacological modalities in order to enable them to make the best choices for the treatment of their patients.


Subject(s)
Acetaminophen/therapeutic use , Analgesics, Non-Narcotic/therapeutic use , Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Osteoarthritis/drug therapy , Pain/drug therapy , Humans , Osteoarthritis/complications , Pain/etiology , Quality of Life
3.
Cureus ; 10(12): e3750, 2018 Dec 18.
Article in English | MEDLINE | ID: mdl-30800555

ABSTRACT

General practitioners (GPs) are often the first clinicians to encounter patients with trigeminal neuralgia (TN). Given the gravity of the debilitating pain associated with TN, it is important for these clinicians to learn how to accurately diagnose and manage this illness. The objective of this article is to provide an up-to-date literature review regarding the presentation, classification, diagnosis, and the treatment of TN. This article also focuses on the long-term management of these patients under the care of GPs. GPs play an important role in the management of patients with TN by following the evidence-based management guidelines. The most important aspects of the management of TN are discussed in this review article.

4.
Oral Maxillofac Surg Clin North Am ; 28(3): 351-70, 2016 Aug.
Article in English | MEDLINE | ID: mdl-27475511

ABSTRACT

Advances in diagnostic modalities have improved the understanding of the pathophysiology of neuropathic pain involving head and face. Recent updates in nomenclature of cranial neuralgias and facial pain have rationalized accurate diagnosis. Clear diagnosis and localization of pain generators are paramount, leading to better use of medical and targeted surgical treatments.


Subject(s)
Cranial Nerve Diseases/diagnosis , Cranial Nerve Diseases/drug therapy , Facial Pain/diagnosis , Facial Pain/drug therapy , Nerve Compression Syndromes/diagnosis , Nerve Compression Syndromes/drug therapy , Neuralgia/diagnosis , Neuralgia/drug therapy , Cranial Nerve Diseases/classification , Diagnosis, Differential , Facial Pain/classification , Humans , Nerve Compression Syndromes/classification , Neuralgia/classification , Pain Management , Pain Measurement , Risk Factors
5.
J Pain Res ; 6: 617-23, 2013.
Article in English | MEDLINE | ID: mdl-23946668

ABSTRACT

The use of spinal cord stimulation (SCS) devices to treat chronic, refractory neuropathic pain continues to expand in application. While device-related complications have been well described, inflammatory reactions to the components of these devices remain underreported. In contrast, hypersensitivity reactions associated with other implanted therapies, such as endovascular and cardiac rhythm devices, have been detailed. The purpose of this case series is to describe the clinical presentation and course of inflammatory reactions as well as the histology of these reactions. All patients required removal of the entire device after developing inflammatory reactions over a time course of 1-3 months. Two patients developed a foreign body reaction in the lead insertion wound as well as at the implantable pulse generator site, with histology positive for giant cells. One patient developed an inflammatory dermatitis on the flank and abdomen that resolved with topical hydrocortisone. "In vivo" testing with a lead extension fragment placed in the buttock resulted in a negative reaction followed by successful reimplantation of an SCS device. Inflammatory reactions to SCS devices can manifest as contact dermatitis, granuloma formation, or foreign body reactions with giant cell formation. Tissue diagnosis is essential, and is helpful to differentiate an inflammatory reaction from infection. The role of skin patch testing for 96 hours may not be suited to detect inflammatory giant cell reactions that manifest several weeks post implantation.

6.
Clin J Pain ; 28(7): 646-51, 2012 Sep.
Article in English | MEDLINE | ID: mdl-22699133

ABSTRACT

Loin pain hematuria syndrome (LPHS) is a rare pain syndrome, which is somewhat poorly characterized and challenging to treat. The condition of LPHS is still controversial and there is no consensus of validated diagnostic criteria or optimal treatment strategies. The epidemiology of LPHS is unknown and the mechanisms/etiologies contributing to LPHS remain uncertain. There exists some debate whether LPHS represents neuropathic pain or visceral pain. Curiously, for such a controversial pain syndrome there is substantially more written in the literature regarding surgical-type treatments than conservative treatments. A brief review of LPHS potential pathophysiology and potential treatment approaches is presented.


Subject(s)
Hematuria/complications , Neuralgia/complications , Visceral Pain/complications , Humans
7.
Headache ; 52(8): 1283-95, 2012 Sep.
Article in English | MEDLINE | ID: mdl-22512348

ABSTRACT

OBJECTIVE: We investigated in a sham-controlled trial the analgesic effects of a 4-week treatment of transcranial direct current stimulation (tDCS) over the primary motor cortex in chronic migraine. In addition, using a high-resolution tDCS computational model, we analyzed the current flow (electric field) through brain regions associated with pain perception and modulation. METHODS: Thirteen patients with chronic migraine were randomized to receive 10 sessions of active or sham tDCS for 20 minutes with 2 mA over 4 weeks. Data were collected during baseline, treatment and follow-up. For the tDCS computational analysis, we adapted a high-resolution individualized model incorporating accurate segmentation of cortical and subcortical structures of interest. RESULTS: There was a significant interaction term (time vs group) for the main outcome (pain intensity) and for the length of migraine episodes (ANOVA, P < .05 for both analyses). Post-hoc analysis showed a significant improvement in the follow-up period for the active tDCS group only. Our computational modeling studies predicted electric current flow in multiple cortical and subcortical regions associated with migraine pathophysiology. Significant electric fields were generated, not only in targeted cortical regions but also in the insula, cingulate cortex, thalamus, and brainstem regions. CONCLUSIONS: Our findings give preliminary evidence that patients with chronic migraine have a positive, but delayed, response to anodal tDCS of the primary motor cortex. These effects may be related to electrical currents induced in pain-related cortical and subcortical regions.


Subject(s)
Analgesia/methods , Electric Stimulation Therapy/methods , Migraine Disorders/therapy , Motor Cortex/physiopathology , Nerve Net/physiopathology , Adolescent , Adult , Female , Humans , Male , Middle Aged , Migraine Disorders/physiopathology , Pain/physiopathology , Pain Management , Pain Measurement , Pain Perception/physiology , Single-Blind Method , Treatment Outcome
8.
Pain Physician ; 14(4): 371-6, 2011.
Article in English | MEDLINE | ID: mdl-21785480

ABSTRACT

BACKGROUND: Chronic lumbosacral radicular pain is a common source of radiating leg pain seen in pain management patients. These patients are frequently managed conservatively with multiple modalities including medications, physical therapy, and epidural steroid injections. Radiofrequency has been used to treat chronic radicular pain for over 30 years; however, there is a paucity of literature about the safety and efficacy of repeat radiofrequency lesioning. OBJECTIVES: To determine the safety, success rate, and duration of pain relief of repeat pulsed radiofrequency (PRF) and continuous radiofrequency (CRF) lesioning of the dorsal root ganglion (DRG)/ sacral segmental nerves (SN) in patients with chronic lumbosacral radicular pain. STUDY DESIGN: Retrospective chart review SETTING: Outpatient multidisciplinary pain center METHODS: Medical record review of patients who were treated with pulsed and continuous radiofrequency lesioning of the lumbar dorsal root ganglia and segmental nerves and who reported initial success were evaluated for recurrence of pain and repeat radiofrequency treatment. Responses to subsequent treatments were compared to initial treatments for success rates, average duration of relief, and adverse neurologic side-effects. LIMITATIONS: Retrospective chart review without a control group. RESULTS: Twenty-six women and 24 men were identified who received 50% pain relief or better after PRF and CRF of the lumbar DRG/ sacral SN for lumbosacral radicular pain. The mean age was 62 years (range, 25-86). The mean duration of relief for the 40 patients who had 2 treatments was 4.7 months (range 0-24; Se [standard error] 0.74). Twenty-eight patients had 3 treatments with an average duration of relief of 4.5 months (range 0-19 months; Se 0.74). Twenty patients had 4 treatments with a mean duration of relief of 4.4 months (range 0.5-18; Se 0.95) and 18 patients who had 5 or more treatments received an average duration of relief of 4.3 months (range 0.5-18; Se 1.03). The average duration of relief and success frequency remained constant after each subsequent radiofrequency treatment. Of the 50 total patients, there was only 1 reported complication, specifically, transient thigh numbness which resolved after one week. CONCLUSIONS: Repeated pulsed and continuous radiofrequency ablation of the lumbar dorsal root ganglion/segmental nerve shows promise to be a safe and effective long-term palliative management for lumbosacral radicular pain in some patients.


Subject(s)
Catheter Ablation/methods , Ganglia, Spinal/surgery , Neuralgia/surgery , Radiculopathy/surgery , Radiofrequency Therapy , Adult , Aged , Aged, 80 and over , Catheter Ablation/adverse effects , Female , Humans , Male , Middle Aged , Neuralgia/etiology , Radiculopathy/complications , Retrospective Studies
9.
Headache ; 50(6): 1064-9, 2010 Jun.
Article in English | MEDLINE | ID: mdl-20618819

ABSTRACT

OBJECTIVE: To report a case of improved pain control and function in a patient with chronic migraine after treatment with auriculotemporal nerve stimulation. METHODS: The patient is a 52-year-old woman with refractory pain in the bilateral temporal distribution and marked phonophobia as a result of chronic migraine. RESULTS: After a successful trial period, the patient underwent implantation of bilateral peripheral nerve stimulators targeting the auriculotemporal nerves. At 16 months of follow up, her average pain intensity declined from 8-9/10 on the numeric rating scale to 5/10. Her function improved as assessed by the Migraine Disability Assessment, from total disability (grade IV) to mild disability (grade II). Her phonophobia became far less debilitating. CONCLUSION: Auriculotemporal nerve stimulation may be useful tool in the treatment of refractory pain in the temporal distribution due to chronic migraine.


Subject(s)
Electric Stimulation Therapy/methods , Mandibular Nerve , Migraine Disorders/therapy , Pain, Intractable/therapy , Electrodes, Implanted , Female , Humans , Middle Aged , Pain Measurement , Treatment Outcome
10.
Ann Neurol ; 68(1): 81-91, 2010 Jul.
Article in English | MEDLINE | ID: mdl-20582997

ABSTRACT

OBJECTIVE: Focal somatic pain can evolve into widespread hypersensitivity to nonpainful and painful skin stimuli (allodynia and hyperalgesia, respectively). We hypothesized that transformation of headache into whole-body allodynia/hyperalgesia during a migraine attack is mediated by sensitization of thalamic neurons that process converging sensory impulses from the cranial meninges and extracephalic skin. METHODS: Extracephalic allodynia was assessed using single unit recording of thalamic trigeminovascular neurons in rats and contrast analysis of blood oxygenation level-dependent (BOLD) signals registered in functional magnetic resonance imaging (fMRI) scans of patients exhibiting extracephalic allodynia. RESULTS: Sensory neurons in the rat posterior thalamus that were activated and sensitized by chemical stimulation of the cranial dura exhibited long-lasting hyperexcitability to innocuous (brush, pressure) and noxious (pinch, heat) stimulation of the paws. Innocuous, extracephalic skin stimuli that did not produce neuronal firing at baseline (eg, brush) became as effective as noxious stimuli (eg, pinch) in eliciting large bouts of neuronal firing after sensitization was established. In migraine patients, fMRI assessment of BOLD signals showed that brush and heat stimulation at the skin of the dorsum of the hand produced larger BOLD responses in the posterior thalamus of subjects undergoing a migraine attack with extracephalic allodynia than the corresponding responses registered when the same patients were free of migraine and allodynia. INTERPRETATION: We propose that the spreading of multimodal allodynia and hyperalgesia beyond the locus of migraine headache is mediated by sensitized thalamic neurons that process nociceptive information from the cranial meninges together with sensory information from the skin of the scalp, face, body, and limbs.


Subject(s)
Migraine Disorders/physiopathology , Pain/physiopathology , Thalamus/physiopathology , Action Potentials , Adolescent , Adult , Animals , Cerebrovascular Circulation , Dura Mater/physiopathology , Hot Temperature , Humans , Magnetic Resonance Imaging , Male , Microelectrodes , Middle Aged , Oxygen/blood , Physical Stimulation , Rats , Rats, Sprague-Dawley , Sensory Receptor Cells/physiology , Thalamus/blood supply , Young Adult
11.
Pain Med ; 11(6): 920-41, 2010 Jun.
Article in English | MEDLINE | ID: mdl-20492571

ABSTRACT

Using functional magnetic resonance imaging (fMRI) methods, we evaluated the effects of lamotrigine vs placebo in a double-blind 1:1 randomized trial. Six patients with neuropathic pain were recruited for the study. All subjects had baseline pain >4/10 on a visual analog scale (VAS) and allodynia to brush as inclusion criteria for the study. Patients underwent two fMRI sessions, with half of the subjects receiving placebo first and half receiving drug first (based on the blinding protocol). Lamotrigine decreased their average pain intensity level from 5.6 to 3.5 on a VAS. All subjects had brush, cold, and heat applied to the affected and mirror-unaffected sides of their face. The results show: 1) in a small cohort, lamotrigine had a significant effect on heat VAS but not on the other stimuli; and 2) contrast analysis of fMRI results for heat stimuli applied to the affected face for lamotrigine vs placebo produced an overall decrease in blood oxygen dependent level signal, suggesting a potential inhibitory effect of the drug on predominantly cortical regions (frontal, parietal, and temporal).


Subject(s)
Anticonvulsants/therapeutic use , Pain/drug therapy , Triazines/therapeutic use , Trigeminal Neuralgia/drug therapy , Adult , Amines , Brain/anatomy & histology , Brain/physiology , Cold Temperature , Cross-Over Studies , Cyclohexanecarboxylic Acids , Double-Blind Method , Female , Gabapentin , Hot Temperature , Humans , Lamotrigine , Magnetic Resonance Imaging , Male , Middle Aged , Pain/physiopathology , Pain Measurement , Placebos/therapeutic use , Psychiatric Status Rating Scales , Touch/physiology , Treatment Outcome , Trigeminal Neuralgia/physiopathology , gamma-Aminobutyric Acid
12.
Circulation ; 121(12): 1406-12, 2010 Mar 30.
Article in English | MEDLINE | ID: mdl-20231534

ABSTRACT

BACKGROUND: Clinical observations of migraine headache symptoms in patients with a patent foramen ovale (PFO), both of which conditions are highly prevalent, have raised the question of a possible pathophysiological relationship. We sought to evaluate the assumption of an association between migraine headaches and the presence of PFO by use of a large case-control study. METHODS AND RESULTS: We conducted a case-control study to assess the prevalence of PFO in subjects with and without migraine. Case subjects were those with a history of migraine (diagnosed by neurologists at a specialty academic headache clinic). Control subjects were healthy volunteers without migraine 1:1 matched on the basis of age and sex with case subjects. Presence of PFO was determined by transthoracic echocardiogram with second harmonic imaging and transcranial Doppler ultrasonography during a standardized procedure of infused agitated saline contrast with or without Valsalva maneuver and a review of the results by experts blinded to case-control status. PFO was considered present if both studies were positive. Odds ratios were calculated with conditional logistic regression in the matched cohort (n=288). In the matched analysis, the prevalence of PFO was similar in case and control subjects (26.4% versus 25.7%; odds ratio 1.04, 95% confidence interval 0.62 to 1.74, P=0.90). There was no difference in PFO prevalence in those with migraine with aura and those without (26.8% versus 26.1%; odds ratio 1.03, 95% confidence interval 0.48 to 2.21, P=0.93). CONCLUSIONS: We found no association between migraine headaches and the presence of PFO in this large case-control study.


Subject(s)
Foramen Ovale, Patent/epidemiology , Migraine Disorders/epidemiology , Adult , Case-Control Studies , Electrocardiography , Female , Foramen Ovale, Patent/complications , Humans , Male , Middle Aged , Migraine Disorders/etiology , Odds Ratio , Prevalence , Ultrasonography, Doppler, Transcranial
13.
Anesthesiology ; 112(3): 711-8, 2010 Mar.
Article in English | MEDLINE | ID: mdl-20179510

ABSTRACT

BACKGROUND: Medical errors exact an inordinate toll on healthcare costs. One of the most publicized and analyzed type of medical error is wrong-site surgery. Yet, despite the burgeoning number of procedures performed, no literature exists on wrong-site pain management injections. The purpose of this study was to estimate the relative incidence and determine the causes of wrong-site pain management procedures. METHODS: Quality improvement records were examined during a 2-yr period from four civilian academic teaching hospitals, three military treatment facilities, and three private practices, for "sentinel" events involving wrong-site pain management procedures. A total of 13 cases (incidence 0.027%; 95% CI 0.01-0.05%) were identified from approximately 48,941 collective procedures of which 52.4% were deemed to be "at risk" for the occurrence. Root cause analyses were then conducted to determine the origin of each error. RESULTS: The 13 cases included five wrong-side transforaminal epidural steroid injections, six other wrong-side injections, and two wrong-level minimally invasive surgical procedures. In only one case was the "universal protocol" completely followed, and in nine procedures, multiple lapses occurred in protocol. Three patients had bilateral pathology, and in seven cases, the patient knew at the time that the wrong side was being injected. In no instance did any technical, legal, or professional consequences ensue from the error. CONCLUSIONS: Wrong-site nerve blocks occur more frequently in pain management centers than has previously been acknowledged. Adaptation of the universal protocol to nerve blocks and strict adherence to widely accepted guidelines may prevent wrong-site interventional pain procedures.


Subject(s)
Medical Errors/statistics & numerical data , Nerve Block/adverse effects , Pain/drug therapy , Pain/epidemiology , Adult , Aged , Female , Guidelines as Topic , Hospitals, Military , Hospitals, Teaching , Humans , Male , Medical Errors/economics , Middle Aged , Minimally Invasive Surgical Procedures , Nerve Block/economics , Pain/economics , Pain Clinics , Quality Assurance, Health Care , United States/epidemiology
14.
Clin J Pain ; 25(8): 691-5, 2009 Oct.
Article in English | MEDLINE | ID: mdl-19920718

ABSTRACT

OBJECTIVE: Based on evidence showing that electrical stimulation of the nervous system is an effective method to decrease chronic neurogenic pain, we aimed to investigate whether the combination of 2 methods of electrical stimulation-a method of peripheral stimulation [transcutaneous electrical nerve stimulation (TENS)] and a method of noninvasive brain stimulation [transcranial direct current stimulation (tDCS)]-induces greater pain reduction as compared with tDCS alone and sham stimulation. METHODS: We performed a preliminary, randomized, sham-controlled, crossover, clinical study in which 8 patients were randomized to receive active tDCS/active TENS ("tDCS/TENS" group), active tDCS/sham TENS ("tDCS" group), and sham tDCS/sham TENS ("sham" group) stimulation. Assessments were performed immediately before and after each condition by a blinded rater. RESULTS: The results showed that there was a significant difference in pain reduction across the conditions of stimulation (P=0.006). Post hoc tests showed significant pain reduction as compared with baseline after the tDCS/TENS condition [reduction by 36.5% (+/-10.7), P=0.004] and the tDCS condition [reduction by 15.5% (+/-4.9), P=0.014], but not after sham stimulation (P=0.35). In addition, tDCS/TENS induced greater pain reduction than tDCS (P=0.02). CONCLUSIONS: The results of this pilot study suggest that the combination of TENS with tDCS has a superior effect compared with tDCS alone.


Subject(s)
Brain/physiology , Electric Stimulation Therapy , Pain Management , Transcutaneous Electric Nerve Stimulation , Adult , Aged , Aged, 80 and over , Arm , Chronic Disease , Combined Modality Therapy , Double-Blind Method , Electric Stimulation Therapy/adverse effects , Endpoint Determination , Female , Humans , Male , Middle Aged , Pain Measurement , Transcutaneous Electric Nerve Stimulation/adverse effects
15.
Pain Physician ; 12(5): 893-900, 2009.
Article in English | MEDLINE | ID: mdl-19787016

ABSTRACT

BACKGROUND: Antidepressants are prescribed in a wide range of doses to treat both depression and chronic pain, with optimal psychopharmacology individualized for each patient. In the past decade more antidepressants from different chemical classes have become available and are being used for the treatment of both chronic pain and depression. OBJECTIVE: To review the utilization pattern changes and compare response rates of different classes and doses of antidepressants for various pain conditions in the context of multimodal therapies. DESIGN: Chart review. METHODS: We reviewed 5,916 records at an outpatient multidisciplinary pain center. Of these, 379 records were for patients diagnosed with cancer pain. Because the mechanisms and treatment approaches to cancer pain can differ greatly from non-cancer chronic pain, these records were excluded from the analysis. We assessed 1,506 medical records for patients with chronic non-caner pain who had used at least one antidepressant, with the main outcome measure being the Numeric Rating Pain Scale, 0-10. RESULTS: Of the 5,916 charts reviewed, 1,506 (25.4%) chronic non-cancer pain charts recorded the prescription of at least one antidepressant. Most patients received a combination of medications and procedures. Of the 450 patients receiving secondary amines, favorable responses were recorded for 340 (76%) patients, while 103 (23%) did not respond and 7 had unknown responses. Of the 492 patients receiving tertiary amines, favorable responses were recorded for 375 (76%) patients, while 113 (23%) did not respond, and 4 had unknown responses. Of the 533 patients receiving SSRI/SNRIs, favorable responses were recorded for 382 (72%) patients, while 147 (28%) did not respond, and 4 had unknown responses. Of the 369 patients receiving atypical antidepressants, favorable responses were recorded for 272 (74%) patients, while 94 (25%) did not respond, and 3 had unknown responses. LIMITATIONS: A retrospective study design and the use of antidepressants as a part of multimodal treatment of pain. CONCLUSION: The data suggest that in the context of multimodal treatment for chronic pain, antidepressant therapy at both low and therapeutic doses demonstrates similar response rates. Tricyclic antidepressants (TCAs), which include secondary and tertiary amines, as well as SSRI/SNRIs and atypicals, all appear to show similar favorable response rates.


Subject(s)
Antidepressive Agents/administration & dosage , Pain/drug therapy , Adult , Aged , Aged, 80 and over , Antidepressive Agents, Tricyclic/administration & dosage , Chronic Disease/therapy , Combined Modality Therapy/methods , Dose-Response Relationship, Drug , Female , Humans , Male , Middle Aged , Outcome Assessment, Health Care/methods , Pain Clinics/statistics & numerical data , Pain Management , Pain Measurement/methods , Pain Threshold/drug effects , Patient Care Team , Retrospective Studies , Selective Serotonin Reuptake Inhibitors/administration & dosage , Treatment Outcome , Young Adult
16.
Curr Rheumatol Rep ; 11(1): 5-14, 2009 Feb.
Article in English | MEDLINE | ID: mdl-19171106

ABSTRACT

As life expectancy increases every decade, the incidence and prevalence of osteoarthritis (OA) also will increase. Despite progress in our knowledge of the pathophysiology of OA, the management of OA-mediated pain continues to challenge physicians. Concern regarding the cardiovascular effects of cyclooxygenase-2 inhibitors and the gastrointestinal and renal side effects of nonsteroidal anti-inflammatory drugs (NSAIDs) in general has limited the use of these medications in the management of chronic non-cancer pain. Appropriately dosed and monitored use of opioids for OA pain, when more conservative methods have failed, has potentially fewer life-threatening complications associated with it than the more commonly and often less successfully employed pharmacotherapeutic approaches to care. When used as part of a multimodal approach to pain control, opioids are a safe and effective treatment for joint pain, including that of OA. Patients for whom NSAIDs are contraindicated, or for whom combined acetaminophen, tramadol, and NSAID therapy is ineffective, may be started on low-dose opioids and titrated as needed and tolerated. Patient education and informed consent, exercise, complementary medicine, and the use of a controlled substance agreement increases the likelihood of patient compliance with treatment guidelines, improving functional capacity and quality of life.


Subject(s)
Analgesia/methods , Analgesics, Opioid/therapeutic use , Osteoarthritis/drug therapy , Pain/drug therapy , Anti-Inflammatory Agents, Non-Steroidal/adverse effects , Dose-Response Relationship, Drug , Drug Therapy, Combination , Humans , Osteoarthritis/complications , Osteoarthritis/physiopathology , Pain/etiology , Quality of Life
17.
Ann Allergy Asthma Immunol ; 103(6): 496-501, 2009 Dec.
Article in English | MEDLINE | ID: mdl-20084843

ABSTRACT

BACKGROUND: Our knowledge of autoimmune characteristics of chronic idiopathic urticaria (CIU) is limited. OBJECTIVE: To study the demographic, laboratory, and clinical patterns of a cohort of patients with CIU. METHODS: We evaluated 236 patients with CIU seen in a recent 2-year span. For serum basophil activation testing (BAT-CD203), the samples were sent to the National Jewish Medical and Research Center for donor basophil CD203 expression assay (5% cell surface expression was considered a positive result). RESULTS: Of the 236 patients with CIU, 77% were females with a mean age of 39 years. The mean age of males was 43 years. Of patients tested for BAT-CD203 (50 females and 8 males), 38% of females (n = 19) and 13% of males (n = 1) had positive test results. Of the 146 females and 42 males tested for thyroid autoimmunity (TA), 34% of females (n = 50) and 17% of males (n = 7) had underlying TA. Nine BAT-CD203-positive females (47%) had TA compared with 11 of 30 BAT-CD203-negative females (37%). No correlation was found between antinuclear antibodies and BAT-CD203. Cyclosporine or corticosteroids were used in 28% of the study population, with another 16% requiring a trial of additional third-line agents with or without prednisone/cyclosporine. There was no significant difference in the maximum number of medications used in subgroups based on the presence or absence of BAT-CD203 and TA. CONCLUSIONS: The frequency of TA in patients with CIU was 30%, which is higher than that previously reported. The frequency of TA and BAT-CD203 positivity was higher in females. In this clinical cohort, there was no correlation between BAT-CD203 and TA.


Subject(s)
Autoimmunity/immunology , Thyroid Gland/immunology , Urticaria/blood , Urticaria/drug therapy , Urticaria/immunology , Adolescent , Adult , Aged , Aged, 80 and over , Angioedema/complications , Antibodies, Antinuclear/blood , Autoantibodies/blood , Autoantibodies/immunology , Basophil Degranulation Test , Chronic Disease , Cohort Studies , Cyclosporine/therapeutic use , Female , Histamine Antagonists/therapeutic use , Humans , Immunoglobulin E/blood , Male , Middle Aged , Prednisone/therapeutic use , Receptors, IgE/immunology , Retrospective Studies , Skin Tests , Young Adult
18.
Curr Pain Headache Rep ; 12(6): 406-11, 2008 Dec.
Article in English | MEDLINE | ID: mdl-18973732

ABSTRACT

Back pain is one of the most common patient complaints brought forth to physicians. Mechanical back pain accounts for 97% of cases, arising from spinal structures such as bone, ligaments, discs, joints, nerves, and meninges. Acute back pain in the absence of progressive neurologic deficits and other underlying nonmechanical causes may be treated conservatively, with specific emphasis on maintaining activity levels and function. Mechanical back pain persisting for more than 4 to 6 weeks may warrant further diagnostic testing and imaging. Common causes of mechanical back pain include spinal stenosis, herniated discs, zygapophysial joint pain, discogenic pain, vertebral fractures, sacroiliac joint pain, and myofascial pain. A wide variety of treatments are available, with different treatments specifically targeted toward different causes. A balanced approach, which takes into account patient psychosocial factors and incorporates multidisciplinary care, increases the likelihood of success from back pain interventions.


Subject(s)
Low Back Pain/diagnosis , Low Back Pain/therapy , Back Pain/diagnosis , Back Pain/physiopathology , Back Pain/therapy , Humans , Low Back Pain/physiopathology , Pain Measurement/methods , Physical Therapy Modalities/trends , Sciatica/diagnosis , Sciatica/physiopathology , Sciatica/therapy , Treatment Outcome
19.
Pain Physician ; 11(5): 693-7, 2008.
Article in English | MEDLINE | ID: mdl-18850035

ABSTRACT

BACKGROUND AND OBJECTIVE: Epidural steroid injections are commonly used to palliate the symptoms of spinal stenosis. Deep tissue infection is a known potential complication of these injections. There have been no previous published cases of osteomyelitis without epidural abscess after such injections. We present a case in an elderly patient who presented only with persistent axial low back pain following a lumbar epidural steroid injection (LESI). We emphasize early patient evaluation, consideration of infectious predisposing factors, sterile technique, and skin disinfectant. DESIGN: Open-label case report. CASE DESCRIPTION: A 77-year-old diabetic male with a history of radicular pain related to lumbar spinal stenosis was treated successfully several years prior with a series of lumbar epidural steroid injections (LESI) and was re-treated with LESIs for recurrent symptoms. Following his second epidural injection, he presented with back pain and induration at the injection site without fever or neurological deficits. Urgent magnetic resonance imaging (MRI) revealed a soft tissue abscess extending close to the epidural space around the corresponding L4/L5 vertebral level. The patient recovered after incision and drainage of the abscess which was associated with an osteomyelitis of the L4 and L5 vertebral spine. The causative organism was methicillin-resistant Staphylococcus Aureus. CONCLUSION: This case demonstrates that even with proper aseptic techniques, immune-compromised patients who are colonized with an aggressive micro-organism may develop a potentially catastrophic infectious complication if subtle persistent symptomatic complaints are not promptly and carefully evaluated.


Subject(s)
Injections, Epidural/adverse effects , Osteomyelitis/etiology , Aged , Diabetes Mellitus/drug therapy , Humans , Magnetic Resonance Imaging , Male , Osteomyelitis/diagnosis , Steroids/administration & dosage , Steroids/adverse effects
20.
Curr Pain Headache Rep ; 12(5): 350-4, 2008 Oct.
Article in English | MEDLINE | ID: mdl-18765140

ABSTRACT

Trigger points play a part in the development and maintenance of chronic headache states. This article reviews the physiology of trigger points, with a focus on the -latest understanding of their biochemistry. The importance of facial muscle and extraocular muscle trigger points is only beginning to be understood; the data exploring their role in headache are reviewed. The concept of central sensitization and the way in which it relates to trigger points and headache is explained, along with treatment strategies for helping patients with their pain.


Subject(s)
Facial Muscles/physiopathology , Headache/physiopathology , Headache/epidemiology , Humans , Myofascial Pain Syndromes/epidemiology , Myofascial Pain Syndromes/physiopathology , Stress, Psychological/epidemiology , Stress, Psychological/psychology , Tension-Type Headache/epidemiology , Tension-Type Headache/physiopathology
SELECTION OF CITATIONS
SEARCH DETAIL
...